130 related articles for article (PubMed ID: 15554904)
1. Sp3 is involved in the regulation of SOCS3 gene expression.
Ehlting C; Häussinger D; Bode JG
Biochem J; 2005 May; 387(Pt 3):737-45. PubMed ID: 15554904
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2516-28. PubMed ID: 17636039
[TBL] [Abstract][Full Text] [Related]
3. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
[TBL] [Abstract][Full Text] [Related]
4. Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade.
Ehlting C; Lai WS; Schaper F; Brenndörfer ED; Matthes RJ; Heinrich PC; Ludwig S; Blackshear PJ; Gaestel M; Häussinger D; Bode JG
J Immunol; 2007 Mar; 178(5):2813-26. PubMed ID: 17312125
[TBL] [Abstract][Full Text] [Related]
5. The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription.
Bode JG; Ludwig S; Freitas CA; Schaper F; Ruhl M; Melmed S; Heinrich PC; Häussinger D
Biol Chem; 2001 Oct; 382(10):1447-53. PubMed ID: 11727828
[TBL] [Abstract][Full Text] [Related]
6. Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization.
Paul C; Seiliez I; Thissen JP; Le Cam A
Eur J Biochem; 2000 Oct; 267(19):5849-57. PubMed ID: 10998044
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells.
Laubner K; Kieffer TJ; Lam NT; Niu X; Jakob F; Seufert J
Diabetes; 2005 Dec; 54(12):3410-7. PubMed ID: 16306356
[TBL] [Abstract][Full Text] [Related]
8. SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Int J Cancer; 2009 Apr; 124(8):1756-66. PubMed ID: 19115200
[TBL] [Abstract][Full Text] [Related]
9. miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling.
Collins AS; McCoy CE; Lloyd AT; O'Farrelly C; Stevenson NJ
PLoS One; 2013; 8(7):e69090. PubMed ID: 23894411
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
12. Methylation status of the SOCS3 gene in human malignant melanomas.
Tokita T; Maesawa C; Kimura T; Kotani K; Takahashi K; Akasaka T; Masuda T
Int J Oncol; 2007 Mar; 30(3):689-94. PubMed ID: 17273770
[TBL] [Abstract][Full Text] [Related]
13. Modeling regulatory mechanisms in IL-6 signal transduction in hepatocytes.
Singh A; Jayaraman A; Hahn J
Biotechnol Bioeng; 2006 Dec; 95(5):850-62. PubMed ID: 16752369
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation.
Dimitriadis E; Stoikos C; Tan YL; Salamonsen LA
Endocrinology; 2006 Aug; 147(8):3809-17. PubMed ID: 16709613
[TBL] [Abstract][Full Text] [Related]
15. Selective involvement of interleukin-6 in the transcriptional activation of the suppressor of cytokine signaling-3 in the brain during systemic immune challenges.
Lebel E; Vallières L; Rivest S
Endocrinology; 2000 Oct; 141(10):3749-63. PubMed ID: 11014231
[TBL] [Abstract][Full Text] [Related]
16. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the JAK-STAT pathway and SOCS3 in the regulation of adiponectin-generated reactive oxygen species in murine macrophage RAW 264 cells.
Akifusa S; Kamio N; Shimazaki Y; Yamaguchi N; Nonaka K; Yamashita Y
J Cell Biochem; 2010 Oct; 111(3):597-606. PubMed ID: 20564237
[TBL] [Abstract][Full Text] [Related]
18. The effect of burn injury on suppressors of cytokine signalling.
Ogle CK; Kong F; Guo X; Wells DA; Aosasa S; Noel G; Horseman N
Shock; 2000 Sep; 14(3):392-8; discussion 398-9. PubMed ID: 11028562
[TBL] [Abstract][Full Text] [Related]
19. Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line.
Komyod W; Böhm M; Metze D; Heinrich PC; Behrmann I
Mol Cancer Res; 2007 Mar; 5(3):271-81. PubMed ID: 17374732
[TBL] [Abstract][Full Text] [Related]
20. SOCS3 suppresses AP-1 transcriptional activity in neuroblastoma cells through inhibition of c-Jun N-terminal kinase.
Miao T; Wu D; Zhang Y; Bo X; Xiao F; Zhang X; Magoulas C; Subang MC; Wang P; Richardson PM
Mol Cell Neurosci; 2008 Feb; 37(2):367-75. PubMed ID: 18055217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
